← Open Payments lookup

DAVID PALLAS: Open Payments

NPI 1417162611 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,562 in 200 payments from 11 companies in 2025. Trend: 2023 $3,146 · 2024 $3,558 · 2025 $4,562

Food & beverage: $4,445Education: $117
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc32$878
Teva Pharmaceuticals USA, Inc.27$743
Otsuka America Pharmaceutical, Inc.36$595
Alkermes, Inc.21$578
Neurocrine BioSciences, Inc.21$545
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)27$510
E.R. Squibb & Sons, L.L.C.21$405
ABBVIE INC.8$145
Axsome Therapeutics, Inc.3$79
Lundbeck LLC2$48

Products named: INVEGA SUSTENNA, INGREZZA, ARISTADA, CAPLYTA, UZEDY, COBENFY, REXULTI, ABILIFY ASIMTUFII.

Industry payments across NY — which companies pay providers there.